Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Verrone

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Public Health Reports (Washington, D.C. : 1974)|May 1, 1977
Financial expenditures for the care of cerebrovascular disease patients in an urban settingG A Verrone, M F Noe
Melanoma Research|October 9, 1998
Multiple primary melanomas: analysis of 49 casesP Savoia, P Quaglino, A Verrone, et al.
Dermatology (Basel, Switzerland)|August 18, 1999
Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical courseP Quaglino, A Zaccagna, A Verrone, et al.
Leukemia & Lymphoma|January 28, 1999
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOPM T Fierro, P Quaglino, P Savoia, et al.
Journal of Cutaneous Pathology|April 1, 1998
Effects of topical calcipotriol on the expression of adhesion molecules in psoriasisP Savoia, M Novelli, A De Matteis, et al.
The British Journal of Dermatology|June 1, 1996
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseasesM Novelli, P Savoia, M T Fierro, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphomaM T Fierro, G C Doveil, P Quaglino, et al.
The British Journal of Dermatology|February 21, 1998
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous diseaseP Savoia, M T Fierro, M Novelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patientsL Mastorino, S Susca, C Cariti, et al.
The Journal of Dermatological Treatment|September 14, 2022
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeksLuca Mastorino, C Cariti, S Susca, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Public Health Reports (Washington, D.C. : 1974)|May 1, 1977
Financial expenditures for the care of cerebrovascular disease patients in an urban settingG A Verrone, M F Noe
Melanoma Research|October 9, 1998
Multiple primary melanomas: analysis of 49 casesP Savoia, P Quaglino, A Verrone, et al.
Dermatology (Basel, Switzerland)|August 18, 1999
Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical courseP Quaglino, A Zaccagna, A Verrone, et al.
Leukemia & Lymphoma|January 28, 1999
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOPM T Fierro, P Quaglino, P Savoia, et al.
Journal of Cutaneous Pathology|April 1, 1998
Effects of topical calcipotriol on the expression of adhesion molecules in psoriasisP Savoia, M Novelli, A De Matteis, et al.
The British Journal of Dermatology|June 1, 1996
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseasesM Novelli, P Savoia, M T Fierro, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphomaM T Fierro, G C Doveil, P Quaglino, et al.
The British Journal of Dermatology|February 21, 1998
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous diseaseP Savoia, M T Fierro, M Novelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patientsL Mastorino, S Susca, C Cariti, et al.
The Journal of Dermatological Treatment|September 14, 2022
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeksLuca Mastorino, C Cariti, S Susca, et al.
Pageof 2